filmov
tv
FDA Reviewers Reject MDMA Treatment for PTSD

Показать описание
This week, the FDA advisory panel rejected MDMA therapy for PTSD due to concerns over research. Dr. Abdul El-Sayed explains what research shows about MDMA as a cure for PTSD symptoms. He then talks about why the panel rejected the research mainly over how reliable the collected evidence is. When it comes to using evidence for science-backed decisions, proof is everything.
00:00 - FDA advisors rejected MDMA as therapy for PTSD
01:04 - What research says about MDMA as a cure for PTSD
01:50 - Message from our sponsors @MargueriteCaseyFoundation
02:35 - Issues with the study
03:42 - Randomization challenges
00:00 - FDA advisors rejected MDMA as therapy for PTSD
01:04 - What research says about MDMA as a cure for PTSD
01:50 - Message from our sponsors @MargueriteCaseyFoundation
02:35 - Issues with the study
03:42 - Randomization challenges
FDA Reviewers Reject MDMA Treatment for PTSD
FDA advisers reject psychedelic drug MDMA as a PTSD treatment
WATCH LIVE: FDA advisory panel reviews MDMA-drug ‘ecstasy’ to treat PTSD
WZRD News: FDA advisors reject MDMA therapy for PTSD, amid concerns over research
Why the FDA Just Rejected MDMA | 2024 Update
MDMA: What Went Wrong Part 1 | The Carlat Psychiatry Podcast
Preparation for Psychedelic-Assisted Therapy: Legal Risk Assessment and Management
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
Study Confirms What Many Patients Taking Statins Have Said for Years | NBC Nightly News
FDA Investigation - Metformin Risk - NDMA, (& Impact of Lifestyle on OGTT)
Opioid Addiction Meds May Curb Growing Problem of Kratom Dependence, New Research Shows
How much did he get paid for this? Be sure to see the description!
FDA Listening Session: COVID19 Impact on Rare Disease Communities
Psychedelics in the Treatment of Psychiatric Disorders | #eastwestpharma
Office of New Drug (OND) Research: Seeking Collaborators, Funding Opportunities Available (2 of 2)
What you need to know about the dangers of Zantac
Barriers to Clinical Trials for Non-Muscle Invasive Bladder Cancer
Review of Novel Drugs in Psychiatry: Can we move beyond biogenic amines? - Dr. Suneel Katragadda
Webinar — The Many Facets of Early Phase Evaluation of Psychedelics in Psychiatry
The Worst Way to Get Medical Marijuana - Key & Peele
Investigational Drugs & Stem Cell Treatments: Legal and Ethical Considerations of Right to Try L...
Take Brain Health to Heart: Evidence and Public Health Action Webinar (Video)
Case 3: Treating Chronic Graft-Versus-Host Disease
2021 PKD Regulatory Summit: Translational Strategies for ADPKD
Комментарии